| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085853A1 Heterocyclic ester and amide hair growth compositions and uses |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/27/2001 | US6207860 Fluorinating agents, far less potential of violent decomposition and attendant high gaseous by-product evolvement, useful for deoxofluorination of alcohols and ketones, |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207662 Useful in the treatment of central nervous system disorders, psychotic disorders such as schizophrenia |
| 03/22/2001 | WO2001019337A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1063441C 1,3-Oxazin-4-one derivatives process and intermediates for their preparation and their use as herbicides |
| 03/20/2001 | US6204380 Production pyridazine herbicides |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/15/2001 | WO2001018124A1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 03/15/2001 | WO2001018005A1 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/14/2001 | EP1082362A1 Supported group 8-10 transition metal olefin polymerization catalysts |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/13/2001 | US6201130 N-arylsulfonylamino acid omega-amides |
| 03/13/2001 | US6200972 Heterocyclic esters and amides |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/13/2001 | US6200925 As polymerization catalyst |
| 03/08/2001 | WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014347A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 03/01/2001 | WO2001014334A1 Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury |
| 03/01/2001 | WO2001013920A1 Carnitine analogues as topical, microbicidal spermicides |
| 03/01/2001 | DE19941115A1 Neue Benzoxazin- und Bezothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and Bezothiazin derivatives and their use in medicaments |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077959A1 Morpholino ethers |
| 02/27/2001 | US6194612 Template for solution phase synthesis of combination libraries |
| 02/22/2001 | WO2001012614A1 N-oxyl radicals |
| 02/22/2001 | WO2001012601A1 Novel anilide derivatives or salts thereof and drugs containing the same |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19939031A1 N-Oxyl-Radikale N-oxyl radicals |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/21/2001 | EP0975609A4 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/20/2001 | US6191182 Subjecting p-halophenyl alkyl ketone to aminolysis with cyclic secondary amine to form cyclic amine-substituted phenyl alkyl ketone; halogination and reacting with amine compound; stevens rearrangement under basic condition |
| 02/20/2001 | US6191127 Antiinflammatory agents, autoimmune diseases, cardiovascular disorders, nervous system disorders |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/14/2001 | CN1284070A Alicyclic acylated heterocyclic derivatives |
| 02/13/2001 | US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use |
| 02/07/2001 | EP1073662A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073626A1 Azine used as fungicides |
| 02/06/2001 | US6184224 Drug resistance and side effect reduction |
| 01/31/2001 | EP1071426A2 Novel compounds and their use as positive ampa receptor modulators |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/30/2001 | US6180625 Modulating and normalizing an impaired haemostatic balance in a mammal, which method comprises administering an effective amount of novel benzoxazin derivatives; anticoagulants |
| 01/30/2001 | US6180624 Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception |
| 01/30/2001 | US6180354 Metal chelate containing compositions for use in chemiluminescent assays |
| 01/24/2001 | CN1281443A Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 01/23/2001 | US6177564 Process for the synthesis of N-benzyl-3-(4-fluorophenyl)-1-4-oxazin-2-one |
| 01/23/2001 | US6177551 Bridged aromatic substituted amine ligands with donor atoms |
| 01/23/2001 | US6177442 Bicyclic amine derivatives |
| 01/23/2001 | US6177427 Treatment of glaucoma and ocular hypertension |
| 01/23/2001 | US6177422 Benzoxazinone dopamine D4 receptor antagonists |
| 01/18/2001 | WO2001004105A1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
| 01/18/2001 | WO2001003697A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2378014A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors |
| 01/17/2001 | EP0490919B1 Cytoprotective compounds bearing unsaturated hydrocarbon groups having 16 to 20 carbon atoms |
| 01/17/2001 | CN1280575A New tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/17/2001 | CN1280574A New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them |
| 01/17/2001 | CN1060769C 1,4-benzoxazine derivatives, pharmaceutical composition containing the same and use thereof |
| 01/11/2001 | WO2001002861A1 Detection using dendrimers bearing labels and probes |
| 01/11/2001 | WO2001002326A1 Process for the synthesis of (r)-1-(3,5-bis(trifluoromethyl)-phenyl)ethan-1-ol by asymmetric transfer hydrogenation |
| 01/11/2001 | WO2000051546A3 Bupropion metabolites and methods of their synthesis and use |
| 01/11/2001 | CA2376619A1 Detection using dendrimers bearing labels and probes |
| 01/11/2001 | CA2376598A1 Process for the synthesis of (r)-1-(3,5-bis(trifluoromethyl)-phenyl)ethan-1-ol by asymmetric transfer hydrogenation |
| 01/04/2001 | WO2001000566A2 Substituted phenoxyacetic acids |
| 01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
| 01/04/2001 | CA2385798A1 Substituted phenoxyacetic acids |
| 01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
| 01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
| 01/03/2001 | EP1064245A1 Catalytic process for making hydrofluoroethers |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |